Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Preliminary Results

18 Nov 2025 07:00

RNS Number : 8832H
Diploma PLC
18 November 2025
Β 

Β 10-11 CHARTERHOUSE SQUARE, LONDON EC1M 6EE

TELEPHONE: +44 (0)20 7549 5700

18 November 2025

PRELIMINARY RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2025

Β 

Very strong results - ahead of expectations. Great momentumΒ 

Β 

Β 

Β 

FY25

FY24

Change

Revenue

Β£1,524.5m

Β£1,363.4m

+12%

Organic revenue growth

11%

6%

Adjusted operating profit

Β£342.7m

Β£285.0m

+20%

Adjusted operating margin

22.5%

20.9%

+160bps

Statutory operating profit

Β£283.7m

Β£207.4m

+37%

Free cash flow

Β£247.2m

Β£197.9m

+25%

Free cash flow conversion

105%

101%

Adjusted earnings per share

176.0p

145.8p

+21%

Basic earnings per share

137.9p

96.5p

+43%

Leverage

0.8x

1.3x

Total dividend per share

62.3p

59.3p

+5%

ROATCE1

20.9%

19.1%

+180bps

Β 

All alternative performance measures are defined in note 15 to the Condensed Consolidated Financial Statements

1 Return on adjusted trading capital employed as defined in note 15

●

Very strong organic revenue growth of 11%, ahead of expectations. Volume-led growth in all three Sectors. Reported growth of 12%, including +3% net acquisitions partially offset by FX

●

Differentiated value-add model and strong execution: Margin up 160 basis points to 22.5%, ahead of expectations

●

Strong earnings growth reflects ambition, building on long-term track record: FY25 EPS growth of 21%

●

Disciplined returns: 20.9%, up 180 basis points

●

Acquisition momentum: Six deals since start of Q4 for Β£92m at average 8x multiple. Total of seven since start of FY25 in attractive markets like aerospace, defence and IVD. Healthy acquisition pipeline

●

Financial firepower: Strong cash generation, modest leverage at 0.8x

●

Quality and diversity of portfolio: attractive end markets driving structural growth

●

Positive start to new year. FY26 guidance: organic revenue growth of 6%, significantly weighted to H1, and operating margin of c.22.5%Β 

●

Sustainable Quality Compounding

Commenting, Johnny Thomson, Diploma's Chief Executive said:

"It's been another great year. I'd like to thank my brilliant Diploma colleagues for their skill, dedication and passion. They make it happen.

Β 

"These strong results demonstrate how we balance ambitious earnings growth and disciplined returns - in good times and bad - to build on our long track record of sustainable quality compounding.

Β 

"We have great momentum into the new year. The quality and diversity of our portfolio positions us well for structural organic growth. Our acquisition pipeline is healthy. And the team is in great shape. We're just getting started."

Sector performance

●

Controls +20% organic growth: Strong execution and attractive end market exposures. Double-digit growth in Windy City Wire and International Controls. Peerless exceeded expectations

●

Seals +2% organic growth: Sequential improvement in H2. North American Seals strong, International Seals recovered well in Europe while UK remains challenging. Well-positioned for growth

●

Life Sciences +6% organic growth: Strong growth in a tough healthcare market, driven by share gains across medtech and in vitro diagnostics (IVD) markets in Canada and AustraliaΒ 

Β 

Β Β FY26 guidance

●

Organic revenue growth of 6% - with growth from all three Sectors

●

Significantly H1 weighted performance - reflecting very strong H2 comparators

●

Acquisitions announced to date add +2% to reported growth - this will increase if further acquisitions are made

●

Maintaining operating margin at c.22.5%

Β 

Preliminary resultsDiploma's preliminary results for the year ended 30 September 2025 have been submitted in full unedited text to the Financial Conduct Authority's National Storage Mechanism and will be available shortly for inspection at National Storage Mechanism | FCA. The results are also available atΒ http://www.rns-pdf.londonstockexchange.com/rns/8832H_1-2025-11-17.pdf and the corporate website: www.diplomaplc.com.

Β 

Dividends

For the financial year ended 30 September 2025 (FY25), the Board has recommended a final dividend of 44.1p per share (FY24: 42.0p) making the proposed full year dividend 62.3p (FY24: 59.3p), up 5%, in line with the Board's dividend policy.Β 

Β 

The final dividend for FY25 is subject to approval by shareholders at the Annual General Meeting on 14 January 2026 and, if approved, will be paid on 30 January 2026 to shareholders on the register at 16 January 2026. Shares will trade ex-dividend from 15 January 2026.

Β 

Β 

Notes:

Β 

1. Diploma PLC uses alternative performance measures as key financial indicators to assess the underlying performance of the Group. These include organic revenue growth, adjusted operating profit/adjusted operating margin, adjusted earnings per share, free cash flow/free cash flow conversion, leverage and ROATCE. Definitions of these metrics are set out in note 15 to the Condensed Consolidated Financial Statements in this Announcement.

Β 

2. Certain statements contained in this Announcement constitute forward-looking statements. Such forward-looking statements involve risks, uncertainties and other factors which may cause the actual results, performance or achievements of Diploma PLC, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such statements. Such risks, uncertainties and other factors include, among others, exchange rates, general economic conditions and the business environment.

A presentation of the results to analysts and investors will be held at 09:00 GMT. This will be streamed live via webcast and audio conference call and webcast.

Register your attendance for the webcast at:Β  https://brrmedia.news/DPLM_FY25

Conference call dial in details:

●

Dial in: UK-Wide: +44 (0) 33 0551 0200 / UK Toll Free: 0808 109 0700

●

Password: Diploma

Β Β 

A recording of the presentation will be available after the event on our website: https://www.diplomaplc.com/investors/financial-presentations/

Β 

Β Β 

For further information please contact:

Diploma PLC -

+44 (0)20 7549 5700

Johnny Thomson, Chief Executive Officer

Β 

Wilson Ng, Acting Chief Financial Officer

Holly Gillis, Head of Investor Relations

Teneo -

+44 (0)20 7353 4200

Martin Robinson

Camilla Cunningham

Β 

Β NOTE TO EDITORS:

Β 

Diploma PLC is a group of specialist businesses that provide critical products and value-added services to customers across a wide range of markets - where quality, reliability and expertise matter most.

We help our customers run smarter, safer and stronger. We provide the bolts that hold planes and race cars together, design the seals that make wind turbines work, and help surgeons find the best solutions to save lives.

Β 

We employ c.3,400 colleagues across the Group. Our businesses primarily operate across the US, Canada, the UK, Europe and Australia.

Β 

Diploma delivers sustainable quality compounding. Over the last seven years, the Group has grown adjusted earnings per share (EPS) at an average of c.18% p.a. through a combination of organic growth and acquisitions.

Β 

Diploma is a member of the FTSE 100.

Β 

Further information on Diploma PLC can be found atΒ www.diplomaplc.com

Β 

The person responsible for releasing this Announcement is Anna Lawrence, Company Secretary.

LEI: 2138008OGI7VYG8FGR19

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
PREBRBLTMTTBBBA
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.